Amalgamated Bank Cullinan Oncology, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,768 shares of CGEM stock, worth $13,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,768
Previous 1,768
-0.0%
Holding current value
$13,790
Previous $13,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CGEM
# of Institutions
150Shares Held
65.8MCall Options Held
10.6KPut Options Held
917K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$59.7 Million11.28% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$44.9 Million1.7% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.4MShares$34.3 Million9.81% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$30.1 Million0.67% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$27.7 Million0.0% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $356M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...